-transparent.png){kind=logo}
Four alpha-galactosidase gene mutations were identified in Japanese male patients with Fabry disease who had no detectable alpha-galactosidase activity. Two of them were novel mutations, an 11-bp deletion in exon 2 and a g-1 to t substitution at the 3' end of the splice acceptor site in intron 1. The former caused a frameshift and led to the creation of a new stop codon at codon 118. The latter was predicted to provoke aberrant mRNA splicing followed by accelerated degradation of the mRNA. A nonsense mutation, R301X, and a 2-bp deletion starting at nucleotide position 718, which were reported previously, were also identified in unrelated patients.
Related Publications
T Okumiya, and
T Takenaka, and
S Ishii, and
R Kase, and
S Kamei, and
H Sakuraba
November 1990,
American journal of human genetics,
T Okumiya, and
T Takenaka, and
S Ishii, and
R Kase, and
S Kamei, and
H Sakuraba
May 2002,
Molecular genetics and metabolism,
T Okumiya, and
T Takenaka, and
S Ishii, and
R Kase, and
S Kamei, and
H Sakuraba
January 2001,
Journal of human genetics,
T Okumiya, and
T Takenaka, and
S Ishii, and
R Kase, and
S Kamei, and
H Sakuraba
March 2003,
Clinical genetics,
T Okumiya, and
T Takenaka, and
S Ishii, and
R Kase, and
S Kamei, and
H Sakuraba
July 2000,
Journal of investigative medicine : the official publication of the American Federation for Clinical Research,
T Okumiya, and
T Takenaka, and
S Ishii, and
R Kase, and
S Kamei, and
H Sakuraba
December 1999,
Molecular medicine (Cambridge, Mass.),
T Okumiya, and
T Takenaka, and
S Ishii, and
R Kase, and
S Kamei, and
H Sakuraba
March 1994,
Human molecular genetics,
T Okumiya, and
T Takenaka, and
S Ishii, and
R Kase, and
S Kamei, and
H Sakuraba
June 2002,
Molecular medicine (Cambridge, Mass.),
T Okumiya, and
T Takenaka, and
S Ishii, and
R Kase, and
S Kamei, and
H Sakuraba
January 1998,
Human mutation,
T Okumiya, and
T Takenaka, and
S Ishii, and
R Kase, and
S Kamei, and
H Sakuraba
May 1980,
Annals of human genetics,
